Guided Therapeutics Inc – ‘10-Q’ for 9/30/19 – ‘EX-101.SCH’

On:  Monday, 3/9/20, at 4:05pm ET   ·   For:  9/30/19   ·   Accession #:  1121781-20-18   ·   File #:  0-22179

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Guided Therapeutics, Inc.                           HTML    498K 
 2: EX-31       Rule 13A-14(A) / 15(D)-14(A) Certification          HTML     22K 
 3: EX-32       Section 1350 Certification                          HTML     17K 
12: R1          Document and Entity Information                     HTML     49K 
39: R2          Condensed Consolidated Balance Sheets (Unaudited)   HTML    129K 
46: R3          Condensed Consolidated Balance Sheets (Unaudited)   HTML     56K 
                (Parenthetical)                                                  
26: R4          Condensed Consolidated Statements of Operations     HTML     89K 
                (Unaudited)                                                      
11: R5          Condensed Consolidated Statements of Cash Flows     HTML    101K 
                (Unaudited)                                                      
38: R6          1. Organization, Background, and Basis of           HTML     28K 
                Presentation                                                     
45: R7          2. Significant Accounting Policies                  HTML     71K 
27: R8          3. Fair Value of Financial Instruments              HTML     44K 
10: R9          4. Stockholders' Deficit                            HTML     87K 
17: R10         5. Stock Options                                    HTML     20K 
32: R11         6. Litigation and Claims                            HTML     19K 
49: R12         7. Commitments and Contingencies                    HTML     33K 
41: R13         8. Notes Payable                                    HTML     59K 
16: R14         9. Short-Term Convertible Debt                      HTML     40K 
31: R15         10. Convertible Debt in Default                     HTML     63K 
47: R16         11. Income (Loss) Per Common Share                  HTML     26K 
40: R17         12. Subsequent Events                               HTML     37K 
18: R18         2. Significant Accounting Policies (Policies)       HTML    136K 
30: R19         2. Significant Accounting Policies (Tables)         HTML     48K 
55: R20         3. Fair Value of Financial Instruments (Tables)     HTML     41K 
34: R21         4. Stockholders' Deficit (Tables)                   HTML     64K 
20: R22         7. Commitments and Contingencies (Tables)           HTML     21K 
24: R23         8. Notes Payable (Tables)                           HTML     43K 
54: R24         9. Short-Term Convertible Debt (Tables)             HTML     22K 
33: R25         10. Convertible Debt in Default (Tables)            HTML     21K 
19: R26         11. Income (Loss) Per Common Share (Tables)         HTML     25K 
23: R27         1. Organization, Background, and Basis of           HTML     36K 
                Presentation (Details Narrative)                                 
53: R28         2. Significant Accounting Policies (Details)        HTML     30K 
35: R29         2. Significant Accounting Policies (Details 1)      HTML     31K 
43: R30         2. Significant Accounting Policies (Details 2)      HTML     42K 
50: R31         2. Significant Accounting Policies (Details 3)      HTML     34K 
28: R32         2. Significant Accounting Policies (Details         HTML     30K 
                Narrative)                                                       
13: R33         3. Fair Value of Financial Instruments (Details)    HTML     35K 
44: R34         3. Fair Value of Financial Instruments (Details 1)  HTML     31K 
51: R35         4. Stockholders' Deficit (Details)                  HTML     22K 
29: R36         4. Stockholders' Deficit (Details 1)                HTML     26K 
14: R37         4. Stockholders' Deficit (Details 2)                HTML    118K 
42: R38         7. Commitments and Contingencies (Details)          HTML     30K 
52: R39         8. Notes Payable (Details)                          HTML     52K 
36: R40         8. Notes Payable (Details 1)                        HTML     37K 
56: R41         8. Notes Payable (Details 2)                        HTML     39K 
25: R42         9. Short-Term Convertible Debt (Details)            HTML     32K 
21: R43         10. Convertible Debt in Default (Details)           HTML     26K 
37: R44         11. Income (Loss) Per Common Share (Details)        HTML     46K 
48: XML         IDEA XML File -- Filing Summary                      XML     99K 
22: EXCEL       IDEA Workbook of Financial Reports                  XLSX     79K 
 4: EX-101.INS  XBRL Instance -- gthp-20190930                       XML   1.30M 
 6: EX-101.CAL  XBRL Calculations -- gthp-20190930_cal               XML    152K 
 7: EX-101.DEF  XBRL Definitions -- gthp-20190930_def                XML    342K 
 8: EX-101.LAB  XBRL Labels -- gthp-20190930_lab                     XML    642K 
 9: EX-101.PRE  XBRL Presentations -- gthp-20190930_pre              XML    529K 
 5: EX-101.SCH  XBRL Schema -- gthp-20190930                         XSD    136K 
15: ZIP         XBRL Zipped Folder -- 0001121781-20-000018-xbrl      Zip    115K 

‘EX-101.SCH’   —   XBRL Schema — gthp-20190930

This Exhibit is an XBRL XML File.